Evidence map›Paper›PMID 24212473›Full record

ReviewJournal of industrial microbiology & biotechnology2014

Genome-guided discovery of diverse natural products from Burkholderia sp.

Xiangyang Liu, Yi-Qiang Cheng

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of industrial microbiology & biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification of the lipodepsipeptide selethramide encoded in a giant nonribosomal peptide synthetase from aProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Expanding theApplied and environmental microbiology · 2022
    Article
  9. Article
  10. Article
  11. Piperacillin triggers virulence factor biosynthesis via the oxidative stress response inProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xiangyang LiuUNT System College of Pharmacy, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX, 76107, USA.
Yi-Qiang Cheng
University of North Texas Health Science Center · USUniversity of North Texas System · US

Funding

Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer AgentsR01CA152212 · NCI · UNIVERSITY OF WISCONSIN MILWAUKEE · PI CHENG, ERIC YIQIANG · 2010 to 2014
$1.1M
Antibiotics Discovery from the Great LakesR03AI073498 · NIAID · UNIVERSITY OF WISCONSIN MILWAUKEE · PI CHENG, ERIC YIQIANG · 2007 to 2008
$146k
NCI NIH HHS R01 CA152212NCI NIH HHS R01CA152212NIAID NIH HHS R03 AI073498NIAID NIH HHS R03AI073498
6 · The paper itself

Abstract

Burkholderia species have emerged as a new source of diverse natural products. This mini-review covers all of the natural products discovered in recent years from Burkholderia sp. by genome-guided approaches--these refer to the use of bacterial genome sequence as an entry point for in silico structural prediction, wet lab experimental design, and execution. While reliable structural prediction based on cryptic biosynthetic gene cluster sequence was not always possible due to noncanonical domains and/or module organization of a deduced biosynthetic pathway, a molecular genetic method was often employed to detect or alter the expression level of the gene cluster to achieve an observable phenotype, which facilitated downstream natural product purification and identification. Those examples of natural product discovery from Burkholderia sp. provide practical guidance for future exploration of Gram-negative bacteria as a new source of natural products.

Indexed as

Genome, BacterialBiological ProductsBiosynthetic PathwaysBurkholderiaBiological Products

Identifiers

PMID24212473
PMCPMC3946939
OpenAlexW1977421075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.